Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EMN 2018 | Clonal evolution in MM: MGUS and SMM

Nicola Giuliani • 19 Apr 2018
EMN 2018
Multiple Myeloma Rare Diseases Smoldering Myeloma

Nicola Giuliani, MD, PhD, from the University of Parma, Parma, Italy, talks about the clinical approach required when identifying and treating patients with smoldering myeloma. Dr Giuliani was speaking at the 1st European Myeloma Network (EMN) Meeting, held in Turin, Italy.

More from Nicola Giuliani

1:08
Targeting glutamine/glutamate metabolism to improve bone disease in patients with multiple myeloma
Nicola Giuliani • 26 Aug 2022
1:32
Impact of impaired glutamine/glutamate metabolic axis on osteoclast activation in multiple myeloma
Nicola Giuliani • 26 Aug 2022
2:48
Glutamine metabolism as a diagnostic tool for bone disease in patients with multiple myeloma
Nicola Giuliani • 26 Aug 2022
1:39
Therapeutic options for smoldering myeloma
Nicola Giuliani • 19 Apr 2018

Related Videos

4:59
MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meeting
Ola Landgren • 13 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals